000 | 01546 a2200445 4500 | ||
---|---|---|---|
005 | 20250513190121.0 | ||
264 | 0 | _c19990819 | |
008 | 199908s 0 0 eng d | ||
022 | _a0009-2797 | ||
024 | 7 |
_a10.1016/s0009-2797(99)00059-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGordon, R K | |
245 | 0 | 0 |
_aOrganophosphate skin decontamination using immobilized enzymes. _h[electronic resource] |
260 |
_bChemico-biological interactions _cMay 1999 |
||
300 |
_a463-70 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aCholinesterase Inhibitors _xtoxicity |
650 | 0 | 4 |
_aCholinesterase Reactivators _xadministration & dosage |
650 | 0 | 4 |
_aCholinesterases _xmetabolism |
650 | 0 | 4 |
_aDecontamination _xmethods |
650 | 0 | 4 | _aEnzyme Stability |
650 | 0 | 4 |
_aEnzymes, Immobilized _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInactivation, Metabolic |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 |
_aOrganophosphates _xtoxicity |
650 | 0 | 4 |
_aOximes _xadministration & dosage |
650 | 0 | 4 |
_aPolyurethanes _xadministration & dosage |
650 | 0 | 4 |
_aPyridinium Compounds _xadministration & dosage |
650 | 0 | 4 |
_aSkin _xdrug effects |
700 | 1 | _aFeaster, S R | |
700 | 1 | _aRussell, A J | |
700 | 1 | _aLeJeune, K E | |
700 | 1 | _aMaxwell, D M | |
700 | 1 | _aLenz, D E | |
700 | 1 | _aRoss, M | |
700 | 1 | _aDoctor, B P | |
773 | 0 |
_tChemico-biological interactions _gvol. 119-120 _gp. 463-70 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0009-2797(99)00059-9 _zAvailable from publisher's website |
999 |
_c10379460 _d10379460 |